Dr. Reddy's Laboratories (RDY) PT Raised to $40 at Barclays
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Price: $12.27 -1.21%
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Dr. Reddy's Laboratories (NYSE: RDY) to $40.00 (from $39.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- CAE Inc. (CAE:CN) (CAE) PT Raised to Cdn$49 at Desjardins
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
